REDHILL BIOPHARMA LTD. Retained Earnings
REDHILL BIOPHARMA LTD. (RDHL) had Retained Earnings of -$418.12 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:RetainedEarnings · last filed 2025-09-05
- 2025-06-30: Retained Earnings -$418.12M.
- 2024-12-31: Retained Earnings -$414.80M.
- 2024-06-30: Retained Earnings -$410.06M.
- 2023-12-31: Retained Earnings -$407.74M.
| Period end | Retained Earnings |
|---|---|
| 2025-06-30 | -$418.12M 6-K · filed 2025-09-05 |
| 2024-12-31 | -$414.80M 6-K · filed 2025-09-05 |
| 2024-06-30 | -$410.06M 6-K · filed 2024-08-29 |
| 2023-12-31 | -$407.74M 20-F · filed 2025-04-10 |
| 2023-06-30 | -$382.01M 6-K · filed 2023-08-17 |
| 2022-12-31 | -$433.86M 20-F · filed 2024-04-08 |
| 2022-06-30 | -$397.18M 6-K · filed 2022-11-07 |
| 2021-12-31 | -$367.87M 20-F · filed 2023-04-28 |
| 2021-06-30 | -$326.17M 6-K · filed 2021-08-26 |
| 2020-12-31 | -$280.33M 20-F · filed 2022-03-17 |
| 2020-06-30 | -$240.14M 6-K · filed 2020-08-13 |
| 2019-12-31 | -$208.36M 20-F · filed 2021-03-18 |
| 2019-06-30 | -$188.37M 6-K · filed 2019-07-23 |
| 2018-12-31 | -$169.09M 20-F · filed 2020-03-04 |
| 2018-06-30 | -$152.46M 6-K · filed 2018-08-30 |
| 2017-12-31 | -$132.94M 20-F · filed 2019-02-26 |
| 2016-12-31 | -$89.64M 20-F · filed 2018-02-22 |